Australia's IDT gains on progress in deal talks
** Shares of IDT Australia IDT.AX up 4% at A$0.13
** The Australian pharma manufacturer says Myndbio Pty Ltd
has been granted access to due diligence information to progress
discussions for proposed takeover
** Adds talks with Myndbio for proposed A$0.15 per IDT share
takeover continue
** Stock on track to log third straight session of gains, if
trend holds
** Stock has risen ~21% so far this year
(Reporting by Prerna Bedi in Bengaluru)
((Prerna.Bedi@thomsonreuters.com; +91 98052 24616;))
Recent news on IDT Australia
See all newsBrief: IDT Australia Sees Unaudited Fy26 Revenue From Three Verticals To Rise To A$16.8 Million
IDT Australia soars on upgraded annual earnings forecasts
IDT Australia climbs on positive FY26 outlook
Brief: Idt Australia Forecasts FY26 EBITDA Loss Of A$1.5m-A$2m
IDT Australia eyes strongest session in over four years as EBITDA loss narrows